"10.1371_journal.pone.0132919","plos one","2015-07-24T00:00:00Z","So Yoon Ahn; Yun Sil Chang; Dong Kyung Sung; Se In Sung; Hye Soo Yoo; Geun Ho Im; Soo Jin Choi; Won Soon Park","Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; Samsung Biomedical Research Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; Biomedical Research Institute, MEDIPOST Co., Ltd., Seoul, Korea","Conceived and designed the experiments: SYA YSC DKS HSY SIS GHI SJC WSP. Performed the experiments: SYA DKS HSY SIS GHI. Analyzed the data: SYA YSC HSY SIS GHI WSP. Contributed reagents/materials/analysis tools: SJC GHI. Wrote the paper: SYA YSC DKS SIS HSY SJC GHI WSP. Supported cells: SJC. Revised and approved the manuscript: SYA YSC DKS HSY SIS GHI SJC WSP.","Soo Jin Choi is an employee of MEDIPOST Co., Ltd. MEDIPOST Co., Ltd. provided support in the form of a salary for author SJC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Won Soon Park and Yun Sil Chang declare potential conflicts of interest arising from a filed or issued patent titled Composition for treating intraventricular hemorrhage in preterm infants comprising mesenchymal stem cells (filed or issued number:13/655,356 in USA and 1405620 in South Korea) as co-inventors, not as patentees. Geun Ho Im is an employee from the Samsung Biomedical Research Institute (SBRI) which is independent academic institution and is not controlled by or answerable to the commercial company known as Samsung Corporation. Samsung Medical Center is public utility foundation and also administratively separate from the Samsung Corporation. There are no additional patents, products in development or marketed products to declare. These do not alter our adherence to all the PLOS ONE policies on sharing data and materials.","2015","07","So Yoon Ahn","SYA",8,TRUE,8,5,6,8,TRUE,TRUE,FALSE,0,NA,FALSE
